Haisco grants license to Sentivera; ViiV's HIV treatment OK'd for newborns
Haisco Pharmaceutical licenses inflammatory disease drug to Sentivera: The Chinese biotech is granting ex-China rights for the unnamed candidate to US startup Sentivera, which was founded by ARCH Venture Partners and Population ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.